Načítá se...
Recombinant human adenovirus-p53 improves the outcome of mid-late stage pancreatic cancer via arterial infusion
The present study aimed to investigate the therapeutic efficacy and clinical value of recombinant human adenovirus-p53 (rAd-p53) perfusion via the pancreatic artery for the treatment of mid-late stage pancreatic cancer. rAd-p53 (2×10(12) virus particles) in 6 ml normal saline was pushed (intravenous...
Uloženo v:
| Vydáno v: | Oncol Lett |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
D.A. Spandidos
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5696714/ https://ncbi.nlm.nih.gov/pubmed/29181104 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.7058 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|